NCT06180603

Brief Summary

The SPEEDTAP-trial is a prospective, randomised, investigator-initiated, multicenter, clinical superior trial investigating two thoracentesis methods in four emergency departments (ED) in Central Denmark Region. Patients are randomised to either manual fluid removal in the ED or passively fluid drainage using gravity in the radiology department (standard of care). Primary outcome: time from clinical indication to complete drainage and 188 patients will be included. Key secondary outcomes include length of stay, ED admission to ED discharge and safety end-points.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
188

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2024

Typical duration for not_applicable

Geographic Reach
1 country

6 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 9, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 22, 2023

Completed
24 days until next milestone

Study Start

First participant enrolled

January 15, 2024

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

December 5, 2024

Status Verified

December 1, 2024

Enrollment Period

1.9 years

First QC Date

November 9, 2023

Last Update Submit

December 4, 2024

Conditions

Keywords

ThoracentesisEmergency departmentTreatment methods

Outcome Measures

Primary Outcomes (1)

  • Time from identification of the clinical indication for thoracentesis to complete drainage

    Time from identification of the clinical indication for thoracentesis is defined as the time patient is randomized. The time of complete drainage is defined by removal of pigtail catheter

    From date and time for randomization until the date and time removal of catheter, assessed up to 3 month

Secondary Outcomes (10)

  • Hospital length of stay (days)

    Date of admission until date of hospital discharge, assessed up until 3 month

  • Duration of procedure (time)

    from date and time for insertion until date and time for removal, assessed up until 3 month

  • Patients degree of chest discomfort (score)

    from date of indication until removal of catheter, assessed up until 3 month

  • Patients degree of breathlessnesss (score)

    from date of indication until removal of catheter, assessed up until 3 month

  • Patients satisfaction

    On the date of removal, assessed up until 1 month

  • +5 more secondary outcomes

Study Arms (2)

Control group

ACTIVE COMPARATOR

Standard of care thoracentesis in the radiology department ( passively drainage using gravity)

Procedure: Gravity fluid drainage in the radiology department

Intervention group

EXPERIMENTAL

Thoracentesis in the emergency department (manual fluid drainage using a syringe connected to a three-way stopcock)

Procedure: Manual drainage in the emergency department

Interventions

Patients will be referred to the radiology department. Thoracentesis will be performed according to local guidelines.

Control group

Thoracentesis will be performed according to current guidelines in the emergency department. Fluid will manually be drained using a syringe connected to a three-way stopcock. Thoracentesis will be stopped early if:

Intervention group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients ≥ 18 years admitted to the ED
  • Pleural effusion detected by any imaging modality (e.g., bedside ultrasound, chest x-ray, computed tomography)
  • Clinically justified need for thoracentesis ( symptomatic relief and/or define the etiology of the effusion
  • Without contraindication for thoracentesis in the emergency department (e.g., anticoagulant treatment)

You may not qualify if:

  • Life-threatening respiratory distress
  • Not able to give consent
  • Previous pleurodesis
  • Effusion does not appear free-flowing due to septations or loculations / suspected empyema
  • Prior enrollment in the trial
  • If randomization is not possible because decision to insert a pigtail catheter is made in the radiology department

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

Aarhus University Hospital

Aarhus, Central Jutland, 8200, Denmark

NOT YET RECRUITING

Gødstrup Regional Hospital

Gødstrup, Central Jutland, 7400, Denmark

NOT YET RECRUITING

Horsens Regional Hospital

Horsens, Central Jutland, 8700, Denmark

RECRUITING

Randers Regional Hospital

Randers, Central Jutland, 8930, Denmark

RECRUITING

Aalborg University Hospital

Aalborg, North Denmark, Denmark

RECRUITING

Esbjerg sygehus

Esbjerg, South Region Denmark, Denmark

RECRUITING

MeSH Terms

Conditions

Pleural EffusionPleural DiseasesHeart FailureEmergencies

Condition Hierarchy (Ancestors)

Respiratory Tract DiseasesHeart DiseasesCardiovascular DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Sandra T Langsted

    Aarhus University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Bo Løfgren

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 9, 2023

First Posted

December 22, 2023

Study Start

January 15, 2024

Primary Completion

November 30, 2025

Study Completion

December 31, 2025

Last Updated

December 5, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will share

De-identified data necessary to reproduce published results will be made available on reasonable requests.

Time Frame
Six months after the publication of the last results, all de-identified individual patient data will be made available upon request. There will be no predetermined end date for the data sharing.

Locations